Australien - engelsk - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - ofloxacin, quantity: 3 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; sodium chloride; hydrochloric acid; sodium hydroxide; purified water - the treatment of severe bacterial conjunctivitis caused by ofloxacin sensitive organisms in adults. indications as approved 2nd december 1997: ocuflox eye drops are indicated for the treatment of corneal ulcers (bacterial keratitis) and severe bacterial conjunctivitis caused by ofloxacin-sensitive organisms.

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - ofloxacin - eye drops, solution - 3 mg/ml

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - ofloxacin - eye drops, solution - 3 mg/ml

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heel belgium sa-nv - pilocarpus jaborandi d5 110,7 mg; euphrasia officinalis l. d5 110,7 mg; echinacea angustifolia d5 110,7 mg; cochlearia officinalis d5 110,7 mg - eye drops, solution - euphrasia officinalis l.; echinacea; pilocarpus jaborandi; cochlearia officinalis

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

riyadh pharma, saudi arabia - hypromellose, sodium chloride - eye drops - 0.3,0.5 %

Saudi-Arabien - engelsk - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

riyadh pharma, saudi arabia - sodium chloride,hypromellose 2208 (750 mpa.s) - eye drops - 0.5,0.3 %,

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

biopharma ltd. - lomefloxacin - eye drops - .3 gm/100 ml

Egypten - engelsk - EDA (Egyptian Drug Authority)

el nile. - eye drops - 0.3 %

USA - engelsk - NLM (National Library of Medicine)

allergan, inc. - ofloxacin (unii: a4p49jaz9h) (ofloxacin - unii:a4p49jaz9h) - ofloxacin 3 mg in 1 ml - ocuflox® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *efficacy for this organism was studied in fewer than 10 infections ocuflox® solution is contraindicated in patients with a history of hypersensitivity to ofloxacin, to other quinolones, or to any of the components in this medication (see warnings).

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd - ofloxacin -